<DOC>
	<DOCNO>NCT01085175</DOCNO>
	<brief_summary>The purpose clinical study determine optimal image parameter assess safety LMI1195 -101 Heart Failure subject Low High Risk cardiac event .</brief_summary>
	<brief_title>Trial Determine Imaging Parameters LMI1195 Heart Failure Patients Low High Risk Defibrillator Firing</brief_title>
	<detailed_description>- To determine optimal image protocol single dose LMI1195 positron emission tomography ( PET ) intend study population . - To assess safety tolerability LMI1195 patient low risk ventricular arrhythmia ( `` low risk patient '' ) heart failure patient history fire implantable cardioverter defibrillator ( ICD ) within 6 month prior enrollment , document ejection fraction ( EF ) ≤ 35 % , prior diagnosis NYHA Class II-III heart failure ( `` heart failure patient '' ) undergo PET imaging .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Male nonpregnant female ≥ 18 year age body weight &lt; 450 pound Be able lie flat least 2hour interval Have normal leave ventricular ejection fraction ( i.e. , ≥ 55 % cohort one ≤35 % cohort two ) multiple gate acquisition scan ( MUGA ) , echocardiogram single photon emission compute tomography ( SPECT ) within 90 day prior , less 3 day prior enrollment . Have schedule undergo undergone SPECT approve PET perfusion image study perform within 90 day prior , less 3 day prior enrollment . within study timeline must review deem acceptable judgment investigator ) ( Additional More Specific Criteria access contact LMI representative ) Have history diabetes , coronary artery disease , myocardial infarction heart arrhythmia ( except sinus arrhythmia ) , heart failure , cardiomyopathy ( e.g . restrictive , infiltrative hypertrophic cardiomyopathy ) , constrictive pericarditis , myocarditis , complex congenital disease , surgically correctable valvular disease , and/or inoperable , obstructive valvular disease , pacemaker , syncope , transient ischemic attack ( TIA ) cerebrovascular accident ( CVA ) , Parkinson 's disease , degenerative cerebral disease , organ transplantation.significant comorbid condition Have undergone major surgery within 4 week prior enrollment plan within 3 week completion study . Unexplained syncope within 5 year . A life expectancy &lt; 1 year , cause . Are currently participate another clinical trial investigational product . Have clinically significant laboratory abnormality ( e.g. , liver enzymes , creatinine , etc. ) . Have history smoking within 1 month enrollment . History drug alcohol abuse Have history major psychiatric disorder , active alcohol/drug abuse , and/or history noncompliance . Receipt radiopharmaceutical within period equal 10 halflives isotope ( e.g. , 99mTc , period 60 hour ; 111In , period 28 day ) prior enrollment receipt radiopharmaceutical containing iodine within period 3 month prior enrollment . Have receive following medication within 30 day prior enrollment , confound effect autonomic nervous system : albuterol ( Alupent , Ventolin within 24 hour ) , Dobutamine ( Dobutrex ) , Dopamine ( Intropin ) , Epinephrine ( Adrenalin ) , Isoproterenol , Phenylephrine ( NeoSynephrine ) , Metaraminol ( Aramine ) , Norepinephrine ( Levophed ) , furazolidone ( Furoxone ) , tricyclic antidepressant ( Adapin , Asendin , Aventyl , Elavil , Endep , Norpramin , Pamelor , Sinequan , Surmontil , Tofranil , Vivactil ) , guanethidine ( Ismelin ) , methyldopa ( Aldomet ) . Over counter herb report interact adrenergic amine exclude : ephedra ( huang ) , St. John 's wort ; alfalfa ; hibiscus ; ginseng ; angelica ( dong quai ) ; yohimbe . Are suitable subject completion screen trial procedure include PET , scan &amp; laboratory testing , Receipt radiopharmaceutical within period time agent decay background level Have metal remove body locate thorax , Receiving Class I III antiarrhythmic drug therapy , except amiodarone . ( Additional More Specific Criteria access contact LMI representative )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Heart Failure ,</keyword>
	<keyword>PET Imaging ,</keyword>
	<keyword>Implantable Cardioverter-Defibrillator ,</keyword>
	<keyword>Sudden Cardiac Death</keyword>
</DOC>